new-onset GD | Hashimoto’s disease | non-autoimmune thyroid diseases | control | P | |
---|---|---|---|---|---|
n | 227 | 29 | 43 | 37 | |
Females/Males (n) | 174/53 | 22/7 | 31/12 | 27/10 | 0.905 |
Age (y) | 39.05 ± 13.27 | 40.48 ± 10.65 | 45.16 ± 13.89 | 37.30 ± 9.96 | 0.022 |
TRAb (IU/L) | 8.79 (5.09–18.24) | 0.31 (0.30–0.46) | 0.39 (0.30–0.52) | 0.31 (0.30–0.43) | < 0.001 |
TRAb | |||||
Positive | 216 (95.15%) | 1 (3.45%) | 0 (0.00) | 0 (0.00) | < 0.001 |
Negative | 11 (4.85%) | 28 (96.55%) | 43 (100.00%) | 37 (100.00%) | |
TSI (IU/L) | 7.10 (3.13–16.65) | 0.10 (0.10–0.10) | 0.10 (0.10–0.10) | 0.10 (0.10–0.10) | < 0.001 |
TSI | |||||
Positive | 220 (96.92%) | 2 (6.90%) | 2 (4.65%) | 0 (0.00) | < 0.001 |
Negative | 7 (3.08%) | 27 (93.10%) | 41 (95.35%) | 37 (100.00%) |